Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Tophaceous Gout

NCT07089888 is registered in ClinicalTrials.gov with Crystalys Therapeutics as lead sponsor.

NCT NCT07089888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07089888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Tophaceous Gout
Lead sponsor
Crystalys Therapeutics
Phase
Phase 3
Overall status
Recruiting
Start date
August 4, 2025
Completion date
December 31, 2027
Enrollment
250 (estimated)
Sites
95

Conditions

As the registry lists them; a condition with its own page is linked.

tophaceous gout